Drugs / hydroquinidine
hydroquinidine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00927732 | Feb 2009 → Oct 2014 | Brugada syndrome | Nantes University Hospital | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hydroquinidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00927732 ↗ |
| Known as | Dihydroquinidine | ChEMBL registry synonym — accepted as the source's own label CHEMBL531472 ↗ |
| Known as | Hydroconchinine | ChEMBL registry synonym — accepted as the source's own label CHEMBL531472 ↗ |
| Known as | NSC-757410 | ChEMBL registry synonym — accepted as the source's own label CHEMBL531472 ↗ |
| Modality | Small molecule | — CHEMBL531472 ↗ |